CAS RN: 1811-31-0

N-Acetyl-D-galactosamine

Product Availability

Choose a grade to view its available package options.

5 package records5 with current stock1 grade group
Batch No.PackageAvailabilityInquiry
Batchno.20260308 100mg In stock Inquiry
Batchno.20250920 1g In stock Inquiry
Batchno.20250512 250mg In stock Inquiry
Batchno.20251220 25g In stock Inquiry
Batchno.20250815 5g In stock Inquiry
  • Product code: SSC-082361
GET A QUOTE
Historical Factory Record

Historical Supply Reference

This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.

  • Pack sizes on record: 5g
  • Available purity: ≥97%
  • Inventory rows with stock: 0
  • Bulk packaging: confirmed by inquiry
Request Bulk Quote

Reference Pack Sizes

Reference pack sizes are shown below. Final availability, packaging and delivery schedule are confirmed by inquiry.

Recorded sizes, purity and stock details for CAS 1811-31-0
Pack Size Recorded Purity Available Qty Ship From Inquiry
5g ≥97% 0 Out of Stock Hong Kong Inquiry

1811-31-0 / N-[(3R,4R,5R,6R)-2,4,5-trihydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide

Standard CAS: 1811-31-0 Multi CAS: No

Basic Information

CAS
1811-31-0
Multi CAS
No
Molecular Formula
C8H15NO6
Molecular Weight
221.210000
Exact Mass
221.089937
SMILES
CC(=O)N[C@@H]1[C@H]([C@H]([C@H](OC1O)CO)O)O
InChI
InChI=1S/C8H15NO6/c1-3(11)9-5-7(13)6(12)4(2-10)15-8(5)14/h4-8,10,12-14H,2H2,1H3,(H,9,11)/t4-,5-,6+,7-,8?/m1/s1
InChIKey
OVRNDRQMDRJTHS-KEWYIRBNSA-N

Computed Properties

Structural Parameters

Heavy atom count
15
Fraction Csp3
0.88
Rotatable bonds
2
H-bond acceptors
6
H-bond donors
5
Molar refractivity
47.58
TPSA
119.25

LogP / Solubility

WLOGP
-3.08
MLOGP
-2.71
XLogP3
-1.7
Consensus LogP
-2.5
Log S (ESOL)
0.86
Class (ESOL)
Highly soluble
Log S (Ali)
0.85
Class (Ali)
Highly soluble
Log S (SILICOS-IT)
1.22
Class (SILICOS-IT)
Highly soluble

ADME

GI absorption
Low
BBB permeant
No
P-gp substrate
No
CYP1A2 inhibitor
No
CYP2C19 inhibitor
No
CYP2C9 inhibitor
No
CYP2D6 inhibitor
No
CYP3A4 inhibitor
No
Log Kp (skin permeation)
-6.25

Drug-likeness / Medicinal Chemistry

Lipinski
Yes
Ghose
No
Veber
Yes
Egan
Yes
Muegge
No
Bioavailability score
0.55
Leadlikeness
No
Synthetic Accessibility
4

Safety & Transport

GHS Hazard Statements
Not Classified Reported as not meeting GHS hazard criteria by 3 of 3 companies. For more detailed information, please visit ECHA C&L website.

Get In Touch

Contact Us